Back to search

Article

EPIDEMIOLOGY OF LEVODOPA-INDUCED DYSKINESIA: PREVALENCE AND ASSOCIATED CLINICAL FACTORS IN LATIN AMERICA

2025-08-27

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Although levodopa remains the gold standard treatment for Parkinson’s disease (PD), its chronic use is associated with levodopa-induced dyskinesia (LID), a motor complication that impacts prognosis, quality of life, and treatment costs. Most known LID-associated factors have been identified in European-descendant populations. <h4>Objectives</h4> To describe the epidemiology...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6e502bd2-05a3-59d1-b68f-f34448f0c113
DOI
10.1101/2025.08.25.25334104
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
EPIDEMIOLOGY OF LEVODOPA-INDUCED DYSKINESIA: PREVALENCE AND ASSOCIATED CLINICAL FACTORS IN LATIN AMERICADOI 10.1101/2025.08.25.25334104
Select a neighboring publication to make it the new centre.